←
Tim Luongo233 posts
Tim Luongo avatar

Tim Luongo

@timluongo

Early‑stage Biotech Advisor | Founder & Principal @ BridgeLine Translational Partners | Discovery, Nonclinical & Portfolio Strategy • Investor Readiness

◷ Joined August 2015▧ 5 Photos and videos
Jen Kwong avatar
⟳ Tim Luongo retweeted
Jen Kwong@KwongLab·29 Mar 2021

Our new paper is out online! We uncovered a surprising ability of the adult heart to withstand defects to the mtDNA maintenance machinery. The developed vs. developing heart respond very differently to mito dysfunction. #mitochondria #heart journals.physiology.org/doi/…

JJ Watt avatar
⟳ Tim Luongo retweeted
JJ Watt@JJWatt·23 Feb 2021

Mitochondria is the powerhouse of the cell.

Peter Horby @peterhorby.bsky.social avatar
⟳ Tim Luongo retweeted
Peter Horby @peterhorby.bsky.social@PeterHorby·15 Jan 2021

The RECOVERY Data Monitoring Committee reviewed data on patients randomised to convalescent plasma vs. usual care. The preliminary analysis based on 10,406 randomised patients with 1873 reported deaths shows no significant difference in the primary endpoint of 28-day mortality.

Post attachment
Nature Metabolism avatar
⟳ Tim Luongo retweeted
Nature Metabolism@NatMetabolism·22 Dec 2020

#NatMetabPicks | Reporting in @nature, Xiaolu Cambronne (@UTAustin), @JosephABaur & @timluongo (@Penn) identify the mitochondrial NAD+ transporter nature.com/articles/s41586-0…